FDA Grants Intravesical Immunotherapy Priority Review for Bladder Cancer
The priority review was based on findings from an open-label phase III trial, which demonstrated significant activity with MCNA, an immunotherapy that is comprised of mycobacterial cell wall fragments complexed with nucleic acids. Under this review ...
OncLive - Fri, 28 Aug 2015 14:21



The global lung cancer therapeutics market would be driven by increasing ...
Lung cancer also called pulmonary carcinoma is a type of cancer characterized by uncontrolled cell growth in the lungs. There are two types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC); where over 80% of the lung ...
Medgadget.com (blog) - Mon, 17 Aug 2015 14:32



Immunotherapy 'revolutionary' for lung cancer, but questions remain about cost ...
HemOnc Today spoke with lung cancer experts about the promise checkpoint inhibitors have demonstrated for squamous and nonsquamous non–small cell lung cancer, how PD-L1 status may help determine patient eligibility for treatment, and whether cost ...
Healio - Mon, 24 Aug 2015 23:18



Meet the 87-year-old woman who has a five inch HORN growing out of her head
They usually occur on the face, scalp, neck, forearms and the back of the hands where there's the most amount of sun exposure. The horns can be big or small and vary in colour. Squamous cell carcinoma, a non-melanoma type of cancer, can be associated ...
Daily Mail - Thu, 27 Aug 2015 03:54



Five things for pharma marketers to know: Tuesday, August 25
... for Gilotrif (afatinib) as a treatment for patients with advanced squamous cell carcinoma of the lung who had previously undergone first-line chemotherapy. The drug, which is currently approved in the US as a therapy for metastatic non-small cell ...
Medical Marketing and Media - Tue, 25 Aug 2015 08:34

Lung Cancer Surgery Market: Global Industry, size, share and Forecast 2015 ...
Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer classified on the basis of microscopic observation. NSLC accounts for around 80% of the lung cancers whereas SLC accounts for the remaining ...
Medgadget.com (blog) - Sat, 22 Aug 2015 10:59



Early diagnosis critical when dealing with lung cancer
Primary lung cancers arise from cells within the lung. The two most common types are called small-cell lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC). NSCLCs include squamous cell cancers (the most common type of lung cancer), ...
Irish Independent - Tue, 04 Aug 2015 06:30

Lung Cancer Therapeutics Market: Global Industry Growth and Forecast, 2015 ...
Digital Journal - Mon, 03 Aug 2015 07:48

Global Lung Cancer Therapeutics Market: Industry Trends and Analysis, 2015 - 2021
Pipe and cigar smoking are some other causes of lung cancer. Lung cancer is treated through surgery, chemotherapy, radiation therapy, immunotherapy and vaccine therapy. The primary lung carcinomas originate from epithelial cells. Non-small cell lung ...
Industry Today (press release) - Tue, 11 Aug 2015 07:26


<-   1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014